Regional Hypoperfusion Predicts Decline in Everyday Functioning at Three-Year Follow-Up in Older Adults without Dementia
- PMID: 32831202
- PMCID: PMC9491307
- DOI: 10.3233/JAD-200490
Regional Hypoperfusion Predicts Decline in Everyday Functioning at Three-Year Follow-Up in Older Adults without Dementia
Abstract
Background: Increasing evidence indicates that cerebrovascular dysfunction may precede cognitive decline in aging and Alzheimer's disease (AD). Reduced cerebral blood flow (CBF) is associated with cognitive impairment in older adults. However, less is known regarding the association between CBF and functional decline, and whether CBF predicts functional decline beyond cerebrovascular and metabolic risk factors.
Objective: To examine the association between regional CBF and functional decline in nondemented older adults.
Method: One hundred sixty-six (N = 166) participants without dementia from the Alzheimer's Disease Neuroimaging Initiative underwent neuropsychological testing and neuroimaging. Pulsed arterial spin labeling magnetic resonance imaging was acquired to quantify resting CBF. Everyday functioning was measured using the Functional Assessment Questionnaire at baseline and annual follow-up visit across three years.
Results: Adjusting for age, education, sex, cognitive status, depression, white matter hyperintensity volume, cerebral metabolism, and reference (precentral) CBF, linear mixed effects models showed that lower resting CBF at baseline in the medial temporal, inferior temporal, and inferior parietal lobe was significantly associated with accelerated decline in everyday functioning. Results were similar after adjusting for conventional AD biomarkers, including cerebrospinal fluid (CSF) amyloid-β (Aβ) and hyperphosphorylated tau (p-tau) and apolipoprotein E (APOE) ɛ4 positivity. Individuals who later converted to dementia had lower resting CBF in the inferior temporal and parietal regions compared to those who did not.
Conclusion: Lower resting CBF in AD vulnerable regions including medial temporal, inferior temporal, and inferior parietal lobes predicted faster rates of decline in everyday functioning. CBF has utility as a biomarker in predicting functional declines in everyday life and conversion to dementia.
Keywords: Activities of daily living; Alzheimer’s disease; aging; biomarkers; cerebrovascular circulation; dementia; magnetic resonance imaging; neuropsychology; perfusion; regional blood flow.
Conflict of interest statement
CONFLICT OF INTERESTS/DISCLOSURE STATEMENT
The authors have no conflict of interest to report. Dr. Bondi serves as a consultant for Novartis and Eisai and receives royalties from Oxford University Press. The other authors report no disclosures.
Figures

Similar articles
-
Entorhinal Perfusion Predicts Future Memory Decline, Neurodegeneration, and White Matter Hyperintensity Progression in Older Adults.J Alzheimers Dis. 2021;81(4):1711-1725. doi: 10.3233/JAD-201474. J Alzheimers Dis. 2021. PMID: 33967041 Free PMC article.
-
Longitudinal Intraindividual Cognitive Variability Is Associated With Reduction in Regional Cerebral Blood Flow Among Alzheimer's Disease Biomarker-Positive Older Adults.Front Aging Neurosci. 2022 Jul 6;14:859873. doi: 10.3389/fnagi.2022.859873. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35875798 Free PMC article.
-
Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline.J Cereb Blood Flow Metab. 2021 May;41(5):1001-1012. doi: 10.1177/0271678X20935171. Epub 2020 Jul 2. J Cereb Blood Flow Metab. 2021. PMID: 32615887 Free PMC article.
-
Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.J Alzheimers Dis. 2014;42 Suppl 4(Suppl 4):S411-9. doi: 10.3233/JAD-141467. J Alzheimers Dis. 2014. PMID: 25159672 Free PMC article. Review.
-
The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease.Cell Mol Neurobiol. 2016 Mar;36(2):167-79. doi: 10.1007/s10571-015-0261-z. Epub 2016 Feb 22. Cell Mol Neurobiol. 2016. PMID: 26898552 Free PMC article. Review.
Cited by
-
Greater subjective cognitive decline severity is associated with worse memory performance and lower entorhinal cerebral blood flow in healthy older adults.J Int Neuropsychol Soc. 2024 Jan;30(1):1-10. doi: 10.1017/S1355617723000115. Epub 2023 Feb 14. J Int Neuropsychol Soc. 2024. PMID: 36781410 Free PMC article.
-
Arterial spin labeling perfusion MRI in the Alzheimer's Disease Neuroimaging Initiative: Past, present, and future.Alzheimers Dement. 2024 Dec;20(12):8937-8952. doi: 10.1002/alz.14310. Epub 2024 Oct 21. Alzheimers Dement. 2024. PMID: 39428971 Free PMC article. Review.
-
Growth-Associated Protein 43 Levels in the Cerebrospinal Fluid Correspond to the Cerebral Blood Flow Alterations in Alzheimer's Dementia Continuum: An Original Study.Health Sci Rep. 2025 Mar 11;8(3):e70534. doi: 10.1002/hsr2.70534. eCollection 2025 Mar. Health Sci Rep. 2025. PMID: 40078900 Free PMC article.
-
Potential Diagnostic Applications of Multi-Delay Arterial Spin Labeling in Early Alzheimer's Disease: The Chinese Imaging, Biomarkers, and Lifestyle Study.Front Neurosci. 2022 Jul 22;16:934471. doi: 10.3389/fnins.2022.934471. eCollection 2022. Front Neurosci. 2022. PMID: 35937865 Free PMC article.
-
Recent advances in arterial spin labeling perfusion MRI in patients with vascular cognitive impairment.J Cereb Blood Flow Metab. 2023 Feb;43(2):173-184. doi: 10.1177/0271678X221135353. Epub 2022 Oct 25. J Cereb Blood Flow Metab. 2023. PMID: 36284489 Free PMC article. Review.
References
-
- Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr., Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280–292. - PMC - PubMed
-
- Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, Marcus DS, Fagan AM, Goate A, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, Martins RN, Saykin AJ, Masters CL, Ringman JM, Ryan NS, Forster S, Laske C, Schofield PR, Sperling RA, Salloway S, Correia S, Jack C Jr., Weiner M, Bateman RJ, Morris JC, Mayeux R, Brickman AM (2016) White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network. Ann Neurol 79, 929–939. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous